COL4A3 and Alport syndrome: The aim of the current study was to examine the effects of MMF treatment on kidney function and on the phosphorylation status of renal proteins in COL4A3-deficient (COL4A3−/−) mice, which represent an in vivo, non-hypertensive model for the autosomal form of Alport syndrome.